Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/CSTONE-PHARMACEUTICALS-57946082/news/CStone-Pharmaceuticals-prasentiert-Ergebnisse-der-Phase-3-Studie-zu-Sugemalimab-in-der-Erstbehandlu-44242571/?utm_source=whatsapp&utm_medium=social&utm_campaign=share